News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Applied InSilico Announces Its First Top Five Pharmaceutical Customer; GlaxoSmithKline (GSK) Licenses ELE(TM) Evolutionary Learning Environment


11/2/2005 1:42:31 PM

CHIPPENHAM, United Kingdom--(BUSINESS WIRE)--Nov. 2, 2005--Applied InSilico, a provider of analytical solutions for drug discovery and development, today announced that GlaxoSmithKline (GSK) has signed a multi-year agreement for its ELE(tm) (Evolutionary Learning Environment) software platform. Financial details were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES